In the realm of rare genetic disorders, a therapeutic drug is only commercially viable if the patients who need it can actually be found. Historically, the journey to a Friedreich’s Ataxia (FA) diagnosis was a grueling, multi-year "diagnostic odyssey." Patients frequently bounced between pediatricians, orthopedic surgeons, and general neurologists, repeatedly misdiagnosed with conditions...
Romaian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Tiếng Việt